Proteins and Peptides

31 Aug 2007 Pharming Presents Positive Results From European Phase III Trial Of Rhucin(R)
30 Aug 2007 King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
30 Aug 2007 Orexo's treatment for incontinence/nocturia entering Phase I
29 Aug 2007 OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
29 Aug 2007 Human genome sciences completes enrollment of first Phase 3 Albuferon(R) trial ahead of schedule
29 Aug 2007 Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
29 Aug 2007 Ambrilia Completes Patient Recruitment for the Phase 3 Pivotal Clinical Trial of its Prolonged Release Formulation of Octreotide
28 Aug 2007 Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
28 Aug 2007 IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
28 Aug 2007 AKELA Pharma Inc. enrolls first patient in its Phase IIb CGRP trial
25 Aug 2007 Phylogica enters anti-microbial field
24 Aug 2007 Teijin and Chugai enter an agreement to co-develop Ipsen's anti-diabetic medicine in Japan
24 Aug 2007 ProNAi Therapeutics announces first DNAi(R) mechanism of action studies for PNT2258 oncology drug candidate
23 Aug 2007 Nuvelo re-initiates SONOMA-3 trial of Alfimeprase in patients with catheter occlusion
23 Aug 2007 Med Discovery and DRAXIMAGE establish research collaboration
22 Aug 2007 Sinobiomed Completes Evaluation of Preclinical Safety Studies on World's First Recombinant Human Kallikrein
22 Aug 2007 SemBioSys Updates Apo AI Development Program
22 Aug 2007 Artisan Pharma, Inc. launches Phase 2b trial of ART-123 for the treatment of DIC in sepsis
21 Aug 2007 Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
21 Aug 2007 Liraglutide improves glucose control and lowers body weight in two phase 3 studies comprising more than 2,000 patients
21 Aug 2007 Wyeth Receives Approval from European Medicines Agency for New BeneFIX Features
21 Aug 2007 Pharming reports positive results in European placebo-controlled trial Of Rhucin(R) in hereditary angioedema
17 Aug 2007 Jerini Receives EMEA Filing Acceptance of its Marketing Application for Icatibant in the Treatment of Hereditary Angioedema
15 Aug 2007 Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
15 Aug 2007 Altus Pharmaceuticals’ ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top